ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
- Resource Type
- Journal
- Authors
- Feng, Ji; Lu, Pei-zhi; Zhu, Guang-zhi; Hooi, Shing Chung; Wu, Yong; Huang, Xiao-wei; Dai, Hui-qi; Chen, Pan-hong; Li, Zhong-jie; Su, Wen-jing; Han, Chuang-ye; Ye, Xin-ping; Peng, Tao; Zhou, Jing; Lu, Guo-dong
- Source
- ACTA PHARMACOLOGICA SINICA; JUN 15 2020, 11p.
- Subject
- Language
- English
- ISSN
- 17457254